MARKET

ALEC

ALEC

Alector
NASDAQ
2.320
-0.060
-2.52%
After Hours: 2.320 0 0.00% 16:10 03/11 EDT
OPEN
2.350
PREV CLOSE
2.380
HIGH
2.375
LOW
2.210
VOLUME
813.24K
TURNOVER
--
52 WEEK HIGH
3.400
52 WEEK LOW
0.8700
MARKET CAP
256.04M
P/E (TTM)
-1.6718
1D
5D
1M
3M
1Y
5Y
1D
Alector Stock Jumps On Upgrade, But AL101 Interim Data Will Be Key
Seeking Alpha · 10h ago
Alector rises as BTIG upgrades to Buy on strategic shift
Seeking Alpha · 1d ago
This CrowdStrike Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday
Benzinga · 1d ago
Alector Raised to Buy From Neutral by BTIG
Dow Jones · 1d ago
Alector Price Target Announced at $6.00/Share by BTIG
Dow Jones · 1d ago
BTIG Upgrades Alector to Buy, Announces $6 Price Target
Benzinga · 1d ago
ALECTOR INC <ALEC.O>: BTIG RAISES TO BUY FROM NEUTRAL
Reuters · 1d ago
BTIG upgrades Alector to Buy on shift to novel therapeutics
TipRanks · 1d ago
More
About ALEC
Alector, Inc. is a clinical-stage biotechnology company. The Company is focused on developing therapies to counteract the devastating progression of neurodegenerative diseases. It also develops alector brain carrier (ABC), a proprietary blood-brain barrier platform, which is applied to its next-generation product candidates and research pipeline. Its research and drug discovery platform leverages human genetic datasets, advanced tools in bioinformatics and imaging, and insights in neurodegeneration. Its clinical development portfolio includes latozinemab (AL001) and AL101/GSK4527226, while its preclinical and research pipeline candidates include ADP037-ABC, ADP050-ABC, ADP056, and ADP063-ABC/ADP064-ABC. Its first product candidate, latozinemab, is a human recombinant monoclonal antibody that increases the levels of progranulin (PGRN) in the brains of FTD-GRN patients. The AL101/GSK4527226, is a human recombinant monoclonal antibody designed to elevate PGRN levels in the brain.

Webull offers Alector Inc stock information, including NASDAQ: ALEC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ALEC stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ALEC stock methods without spending real money on the virtual paper trading platform.